Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer's disease brain extracts.
Saved in:
| Title: | Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer's disease brain extracts. |
|---|---|
| Authors: | Sandberg A; Alzinova AB, Pepparedsleden 1, SE-431 83, Mölndal, Sweden. anders.sandberg@alzinova.com., Berenjeno-Correa E; Department of Human Genetics, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands.; Department of Functional Genomics, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Rodriguez RC; Department of Neurochemistry, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands., Axenhus M; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Weiss SS; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Batenburg K; Department of Human Genetics, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands.; Department of Functional Genomics, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Hoozemans JJM; Department of Neuropathology, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands., Tjernberg LO; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Scheper W; Department of Human Genetics, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands.; Department of Functional Genomics, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. |
| Source: | Alzheimer's research & therapy [Alzheimers Res Ther] 2022 Dec 29; Vol. 14 (1), pp. 196. Date of Electronic Publication: 2022 Dec 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN: 1758-9193 (Electronic) NLM ISO Abbreviation: Alzheimers Res Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
